Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palifermin dosing for oral mucositis in hematologic malignancies
NCT00109031Phase 3Completed
- Sponsor
- Sobi
- Start
- Jan 2005
- Primary completion
- Feb 2006
- Modality
- Cytokines & Interferons
01
Overview
A Phase 3 trial of palifermin in oral mucositis (OM), sponsored by Sobi. Started Jan 2005; status: completed.
02
Drugs
palifermin
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT00109031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00109031.